Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-052229

Chief Executive Officer sold 1,325 shares at $1.98 ($2,619)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Brainard Diana · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-10-03 Sale : show line 1 in the form 10b5-1 −1,325 $1.98 $2,619 890,558 D
Open-market sales · 1,325 sh · avg $1.98 · $2,619
Loading xslF345X05/doc4.xml…